A roundup of news on drug resistance and other topics in global health.

In research published in the journal PLoS Medicine by GARP affiliates, researchers describe the launch and impact of VINARES, a new initiative to strengthen Vietnam’s capacity for antimicrobial stewardship. [Eureka Alert]

Wired s Superbug blog discusses the major stories in the past few weeks on foodborne illnesses and antibiotic use and resistance in food. [Wired]

An article in Forbes examines the market challenges involved in creating new antibiotics and highlights the efforts of some government agencies to fill gaps that are left by the drug industry and the shortcomings of financial markets. [Forbes]

Research published in the journal EcoHealth provides new evidence of human to wildlife transfer of antibiotic resistance. [TakePart]

A New York Times article reports that India, followed by China and Brazil, has the highest number of cervical cancer deaths. [NYT]

Merck and GlaxoSmithKline have announced that they will cut prices of their vaccines against cervical cancer in poor countries. [NYT]

While the threat of drug-resistant gonorrhea in the US is very real, recent reports of the detection of a rare strain of gonorrhea resistant to ceftriaxone, the last-resort antibiotic to treat gonorrhea, are false. [NBC News]

By creating a mosquito that maintains infection by Wolbachia (a bacterium that makes mosquitoes resistant to the malaria parasite) throughout its lifetime and passes the bacterium to its offspring, researchers demonstrate a new possibility for controlling malaria in a study published in the journal Science. [NPR]

A study published in The Journal of Visualized Experiments (JoVE) describes a quick method to detect antibiotic resistant bacteria by using a biosensor formed by combining bacteriophage and specific antibodies. [Phys.Org]

The President s Malaria Initiative s Seventh Annual Report to the Congress is available online.

A New York Times article explores the possibility and the potential human and economic costs of the spread of new infectious diseases. [NYT]

According to a study published in the journal Small, nanosilver, which is widely used as an antimicrobial agent, also initiated the unexpected emergence, adaptation and abnormally fast growth of one bacterial species. [Asian Scientist]

WHO’s Regional Office for Europe recently released an infographic on antibiotic resistance. [WHO]

Want to receive the weekly digest in your inbox? Enter your email address in the “receive updates” box.

Mongoose image via Tambako the Jaguar/Flickr